ClinConnect ClinConnect Logo
Search / Trial NCT07062809

Comparing the Effects of Sub-Occipital Myofascial Release With and Without SNAG on People With Cervicogenic Dizziness.

Launched by RIPHAH INTERNATIONAL UNIVERSITY · Jul 3, 2025

Trial Information

Current as of July 22, 2025

Not yet recruiting

Keywords

Cervicogenic Dizziness Pain Suboccipital Myofascial Release

ClinConnect Summary

This clinical trial is looking at two types of hands-on treatments to help people who have dizziness caused by problems in the neck, known as cervicogenic dizziness. One treatment is called Sub-Occipital Myofascial Release, which involves gentle pressure and stretching of muscles at the base of the skull. The other treatment adds a technique called Sustained Natural Apophyseal Glide (SNAG), which is a specific way of moving the neck joints to relieve symptoms. The study aims to find out whether combining these two treatments works better than using the muscle release therapy alone.

People who might join this study are adults between 22 and 54 years old who have had dizziness related to neck movement or stiffness for more than three months. They should have a moderate level of difficulty in daily activities due to dizziness. Certain conditions, like recent neck surgery, brain injury, or other types of dizziness caused by inner ear or neurological problems, would exclude someone from joining. If eligible, participants can expect to receive one of the two treatments to see how well it helps reduce their dizziness and neck discomfort. This study is not yet recruiting, but it hopes to provide clearer guidance on effective treatments for dizziness linked to neck issues.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Cervicogenic dizziness patients both male and female.
  • Age group between 22 to 54 Years old.
  • Passive Accessory Assessment of the UCS (C0-1, C1-2, C2-3).
  • Dizziness related to either movements or positions of the cervical spine, or occurring with a stiff or painful neck.
  • Symptoms \> 3 months.
  • Moderate disability score on the Dizziness Handicap Inventory (DHI) \[31-60 points\] .
  • Exclusion Criteria:
  • Conditions for which manual therapy is contraindicated
  • Traumatic brain injury
  • Previous surgery to the upper cervical spine and marked cervical spine disc protrusion
  • By neurologist .Vestibular disorders (e.g. Benign Paroxysmal Positional Vertigo, Meniere's disease, peripheral vestibulopathy)
  • CNS disorder (e.g.cerebellar ataxia, stroke, demyelination)
  • Migraine associated vertigo
  • Psychogenic dizziness
  • Cardiovascular disorders

About Riphah International University

Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.

Locations

Lahore, Punjab, Pakistan

Patients applied

0 patients applied

Trial Officials

Muzna Munir, PHD*

Principal Investigator

Riphah International University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported